fbpx

In Silico Analysis and Docking Study on a Potential Wild-Type, Tumor Suppressor Protein P53 Activator using Thymoquinone

Ahnaf Khan Student, Thomas Jefferson High School for Science and Technology, Alexandria, Virginia ABSTRACT: p53 is a potent tumor suppressor protein that is frequently mutated or inactivated in almost 50% of all human cancers. These statistics, as well as essential functions of p53 in maintaining normal cell cycle and apoptosis, Read more…

Assessing the Development of Artificial Intelligence Technologies In Radiation Therapy and Targeting Irregular Masses

Eric Bear, Jessica Singh, and Michael Wahrman   ABSTRACT The purpose of this paper is to evaluate the use of artificial intelligence in the medical use of particle accelerators for both treatment (radiation therapy) and imaging. We will first discuss the implications of artificial intelligence (AI) on particle accelerators, starting Read more…

Mela-NO-More: Fighting Cancer with Immunotherapy

Author: Anika Markan Introduction: In 2017, approximately 87,110 new cases of  melanoma will be diagnosed and about 9,730 people are expected to die of melanoma. For the past 30 years, the rates of melanoma have been rising (Key Statistics for Melanoma Skin Cancer 1). There are many new treatments being discovered Read more…

%d bloggers like this: